과제정보
This research was supported by the National Research Foundation of Korea (NRF), funded by the Ministry of Science and ICT (NRF-2021R1F1A1046947) and Korea University Ansan Hospital (Grant Number O2207231).
참고문헌
- Biglan KM, Oakes D, Lang AE, Hauser RA, Hodgeman K, Greco B, et al. : A novel design of a phase III trial of isradipine in early Parkinson disease (STEADY-PD III). Ann Clin Transl Neurol 4 : 360-368, 2017
- Bretaud S, Lee S, Guo S : Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease. Neurotoxicol Teratol 26 : 857-864, 2004
- Carlson AP, Hanggi D, Macdonald RL, Shuttleworth CW : Nimodipine reappraised: an old drug with a future. Curr Neuropharmacol 18 : 65-82, 2020
- Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, Tkatch T, et al. : 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature 447 : 1081-1086, 2007
- Chang CC, Cao S, Kang S, Kai L, Tian X, Pandey P, et al. : Antagonism of 4-substituted 1,4-dihydropyridine-3,5-dicarboxylates toward voltagedependent L-type Ca2+ channels Ca V 1.3 and Ca V 1.2. Bioorg Med Chem 18 : 3147-3158, 2010
- Cui X, Gooch H, Petty A, McGrath JJ, Eyles D : Vitamin D and the brain: genomic and non-genomic actions. Mol Cell Endocrinol 453 : 131-143, 2017
- DiPalma JR : Nimodipine in subarachnoid hemorrhage. Am Fam Physician 40 : 143-145, 1989
- Eyles DW, Burne TH, McGrath JJ : Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol 34 : 47-64, 2013
- Eyles DW, Feron F, Cui X, Kesby JP, Harms LH, Ko P, et al. : Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology 34 Suppl 1 : S247-S257, 2009
- Flinn L, Bretaud S, Lo C, Ingham PW, Bandmann O : Zebrafish as a new animal model for movement disorders. J Neurochem 106 : 1991-1997, 2008
- Gooch H, Cui X, Anggono V, Trzaskowski M, Tan MC, Eyles DW, et al. : 1,25-Dihydroxyvitamin D modulates L-type voltage-gated calcium channels in a subset of neurons in the developing mouse prefrontal cortex. Transl Psychiatry 9 : 281, 2019
- Grunblatt E, Mandel S, Youdim MB : MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease: neuroprotective strategies. J Neurol 247 Suppl 2 : II95-II102, 2000
- Guzman JN, Sanchez-Padilla J, Wokosin D, Kondapalli J, Ilijic E, Schumacker PT, et al. : Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 468 : 696-700, 2010
- Han Y, Chen A, Umansky KB, Oonk KA, Choi WY, Dickson AL, et al. : Vitamin D stimulates cardiomyocyte proliferation and controls organ size and regeneration in zebrafish. Dev Cell 48 : 853-863.e5, 2019
- Holzschuh J, Ryu S, Aberger F, Driever W : Dopamine transporter expression distinguishes dopaminergic neurons from other catecholaminergic neurons in the developing zebrafish embryo. Mech Dev 101 : 237-243, 2001
- Ilijic E, Guzman JN, Surmeier DJ : The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease. Neurobiol Dis 43 : 364-371, 2011
- Jeong JY, Kwon HB, Ahn JC, Kang D, Kwon SH, Park JA, et al. : Functional and developmental analysis of the blood-brain barrier in zebrafish. Brain Res Bull 75 : 619-628, 2008
- Kalia LV, Lang AE : Parkinson's disease. Lancet 386 : 896-912, 2015
- Kang S, Cooper G, Dunne SF, Dusel B, Luan CH, Surmeier DJ, et al. : CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease. Nat Commun 3 : 1146, 2012
- Kang S, Cooper G, Dunne SF, Luan CH, James Surmeier D, Silverman RB : Antagonism of L-type Ca2+ channels CaV1.3 and CaV1.2 by 1,4-dihydropyrimidines and 4H-pyrans as dihydropyridine mimics. Bioorg Med Chem 21 : 4365-4373, 2013
- Kupsch A, Sautter J, Schwarz J, Riederer P, Gerlach M, Oertel WH : 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level. Brain Res 741 : 185-196, 1996
- Lam CS, Korzh V, Strahle U : Zebrafish embryos are susceptible to the dopaminergic neurotoxin MPTP. Eur J Neurosci 21 : 1758-1762, 2005
- Lee KS, Huh S, Lee S, Wu Z, Kim AK, Kang HY, et al. : Altered ER-mitochondria contact impacts mitochondria calcium homeostasis and contributes to neurodegeneration in vivo in disease models. Proc Natl Acad Sci U S A 115 : E8844-E8853, 2018
- Lieschke GJ, Currie PD : Animal models of human disease: zebrafish swim into view. Nat Rev Genet 8 : 353-367, 2007
- Miller GW, Gainetdinov RR, Levey AI, Caron MG : Dopamine transporters and neuronal injury. Trends Pharmacol Sci 20 : 424-429, 1999
- Nakajima T, Kitazawa T, Hamada E, Hazama H, Omata M, Kurachi Y : 17beta-estradiol inhibits the voltage-dependent L-type Ca2+ currents in aortic smooth muscle cells. Eur J Pharmacol 294 : 625-635, 1995
- Nedergaard S, Flatman JA, Engberg I : Nifedipine- and omega-conotoxin-sensitive Ca2+ conductances in guinea-pig substantia nigra pars compacta neurones. J Physiol 466 : 727-747, 1993
- Nicotra A, Parvez SH : Cell death induced by MPTP, a substrate for monoamine oxidase B. Toxicology 153 : 157-166, 2000
- Oliveri AN, Glazer L, Mahapatra D, Kullman SW, Levin ED : Developmental exposure of zebrafish to vitamin D receptor acting drugs and environmental toxicants disrupts behavioral function. Neurotoxicol Teratol 81 : 106902, 2020
- Ortner NJ, Striessnig J : L-type calcium channels as drug targets in CNS disorders. Channels (Austin) 10 : 7-13, 2016
- Panula P, Sallinen V, Sundvik M, Kolehmainen J, Torkko V, Tiittula A, et al. : Modulatory neurotransmitter systems and behavior: towards zebrafish models of neurodegenerative diseases. Zebrafish 3 : 235-247, 2006
- Parkinson Study Group : Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD). Mov Disord 28 : 1823-1831, 2013
- Ramirez AD, Wong SK, Menniti FS : Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms. Eur J Pharmacol 475 : 29-35, 2003
- Rink E, Wullimann MF : The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum). Brain Res 889 : 316-330, 2001
- Sallinen V, Torkko V, Sundvik M, Reenila I, Khrustalyov D, Kaslin J, et al. : MPTP and MPP+ target specific aminergic cell populations in larval zebrafish. J Neurochem 108 : 719-731, 2009
- Schoenrock SA, Tarantino LM : Developmental vitamin D deficiency and schizophrenia: the role of animal models. Genes Brain Behav 15 : 45-61, 2016
- Singh A, Verma P, Balaji G, Samantaray S, Mohanakumar KP : Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice. Neurochem Int 99 : 221-232, 2016
- Soman SK, Bazala M, Keatinge M, Bandmann O, Kuznicki J : Restriction of mitochondrial calcium overload by mcu inactivation renders a neuroprotective effect in zebrafish models of Parkinson's disease. Biol Open 8 : bio044347, 2019
- Sugishita K, Li F, Su Z, Barry WH : Anti-oxidant effects of estrogen reduce [Ca2+]i during metabolic inhibition. J Mol Cell Cardiol 35 : 331-336, 2003
- Sulzer D : Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. Trends Neurosci 30 : 244-250, 2007
- Surmeier DJ, Schumacker PT, Guzman JD, Ilijic E, Yang B, Zampese E : Calcium and Parkinson's disease. Biochem Biophys Res Commun 483 : 1013-1019, 2017
- Swaminathan A, Basu M, Bekri A, Drapeau P, Kundu TK : The dietary flavonoid, luteolin, negatively affects neuronal differentiation. Front Mol Neurosci 12 : 41, 2019
- Vaz RL, Outeiro TF, Ferreira JJ : Zebrafish as an animal model for drug discovery in Parkinson's disease and other movement disorders: a systematic review. Front Neurol 9 : 347, 2018
- Wagner M, Moritz A, Volk T : Interaction of gonadal steroids and the glucocorticoid corticosterone in the regulation of the L-type Ca(2+) current in rat left ventricular cardiomyocytes. Acta Physiol (Oxf) 202 : 629-640, 2011
- Xi Y, Ryan J, Noble S, Yu M, Yilbas AE, Ekker M : Impaired dopaminergic neuron development and locomotor function in zebrafish with loss of pink1 function. Eur J Neurosci 31 : 623-633, 2010
- Xi Y, Yu M, Godoy R, Hatch G, Poitras L, Ekker M : Transgenic zebrafish expressing green fluorescent protein in dopaminergic neurons of the ventral diencephalon. Dev Dyn 240 : 2539-2547, 2011
- Xie J, Farage E, Sugimoto M, Anand-Apte B : A novel transgenic zebrafish model for blood-brain and blood-retinal barrier development. BMC Dev Biol 10 : 76, 2010
- Yagami T, Ueda K, Sakaeda T, Itoh N, Sakaguchi G, Okamura N, et al. : Protective effects of a selective L-type voltage-sensitive calcium channel blocker, S-312-d, on neuronal cell death. Biochem Pharmacol 67 : 1153-1165, 2004
- Yang M, Zhou Y, Wan LL, Ye JZ, Lu HL, Huang X, et al. : Luteolin suppresses colonic smooth muscle motility via inhibiting L-type calcium channel currents in mice. Gen Physiol Biophys 39 : 49-58, 2020
- Zhang ZJ, Cheang LC, Wang MW, Lee SM : Quercetin exerts a neuroprotective effect through inhibition of the iNOS/NO system and proinflammation gene expression in PC12 cells and in zebrafish. Int J Mol Med 27 : 195-203, 2011
- Zhang ZJ, Cheang LC, Wang MW, Li GH, Chu IK, Lin ZX, et al. : Ethanolic extract of fructus Alpinia oxyphylla protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish. Cell Mol Neurobiol 32 : 27-40, 2012